Related Experiment Video
Updated: Jan 12, 2026
10:24
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.7K
Advances in minimally traumatic retinal laser therapy
Catherine S Yao1, Yannis M Paulus1,2
1Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Expert Review of Medical Devices
|November 6, 2025
Summary
New laser therapies for retinal vascular diseases offer safer treatment options. These advanced methods aim to preserve vision by minimizing tissue damage, providing a promising alternative to traditional approaches.
Area of Science:
- Ophthalmology
- Medical Technology
- Laser Medicine
Background:
- Conventional retinal laser therapy, used since the 1960s for diseases like diabetic retinopathy, can cause scarring and vision loss.
- Advancements focus on sub-ablative or selective energy delivery to reduce collateral damage and preserve retinal tissue.
Purpose of the Study:
- To review novel, minimally traumatic retinal laser therapies.
- To evaluate their potential as safer alternatives to conventional treatments.
Main Methods:
- Literature search of PubMed/MEDLINE and Embase up to July 2025.
- Focus on micropulse lasers, selective retina therapy, and nanosecond lasers.
Main Results:
- Early results indicate promising outcomes for novel laser therapies.
- These treatments aim for vision preservation with reduced procedural burden.
Conclusions:
- Minimally traumatic retinal lasers represent a significant advancement in managing retinal vascular diseases.
- Further research is needed for standardization, but these therapies offer safer, effective vision-preserving options.
